MS was diagnosed for the first time in 1849. Since then, researchers have been unveiling new discoveries about the disease. Much of this research focuses on stopping disease activity, repairing the nervous system and preventing MS. While there is no known cure for MS, these continued efforts by researchers are moving us closer to a world free of MS.
The most relevant, accurate and timely research information is available to you through the following resources:
- Sign up to receive research updates from the chapter
- View the National MS Society Research Bulletins
- Local clinical trials
Upcoming Research Programs - Register Now!
The MS specialists will discuss:
- Research and new therapies for MS
New data on disease modifying medication
Programs includes brunch!
Researchers pave way for the first coordinated international approach to MS stem cell research.
The guidelines, developed by an international panel of MS experts with input from MS Societies around the world, spell out hope for the future of MS stem cell research and debunk myths about overseas stem cell clinics claiming to cure the condition. The paper appears in the May 6, 2010 issue of Nature Reviews Neurology.
The consensus is timely, since small-scale trials of stem cells, such as adult mesenchymal stem cells (from bone marrow and other bodily tissues), are already underway or in planning stages for the treatment of multiple sclerosis.
A public information booklet on stem cells, “Stem Cell Therapies in MS,” produced in partnership by MS Societies from the UK, USA, Italy, France and Australia and the MS International Federation, summarizes the current status of stem cell research in MS and frequently asked questions, and is available to download (.pdf).
Emerging Therapies Collaborative
The Multiple Sclerosis Emerging Therapies Collaborative has been organized to provide timely, evidence-based resources regarding the known benefits and risks of newly emerging, FDA-approved medications for multiple sclerosis (MS). The Collaborative's goal is to promote optimal, individualized MS treatment by facilitating effective communication and medical decision making for persons affected by MS and health care professionals. This group, which includes the MS Coalition, the American Academy of Neurology, the Multiple Sclerosis VA Centers of Excellence East and West, Can Do MS, Consortium of MS Centers, International Organization of MS Nurses, MS Association of America, MS Foundation, National MS Society, United Spinal Association , Accelerated Cure Project for MS, and the Americas Committee for Treatment and Research in MS will post information and resources for each of the therapies as they gain FDA approval.
Launched in 2011, the Collaborative has as its priority to provide information on MS-specific, (FDA)-approved treatments that have entered the market since 2010. Previously-approved medications will be reviewed in the event of new safety or efficacy data that significantly affect their use in MS treatment.